Blood Pressure Treatments Tied to Longer Survival in Patients with Type 2 Diabetes

In a review and meta-analysis of large-scale randomized controlled trials of blood pressure–lowering treatments over the past 5 decades, each 10 mm Hg lower systolic blood pressure among type 2 diabetics was associated with a 13% lower risk of premature mortality, an 11% lower risk of cardiovascular events, a 12% lower risk of coronary heart disease, a 27% lower risk of stroke, a 17% lower risk of albuminuria, and a 13% lower risk of retinopathy. Lower risks were observed among those with baseline systolic blood pressure levels ≥140 mm Hg. The findings are published in JAMA.

Category:
Subcategory:
Body:

In a review and meta-analysis of large-scale randomized controlled trials of blood pressure–lowering treatments over the past 5 decades, each 10 mm Hg lower systolic blood pressure among type 2 diabetics was associated with a 13% lower risk of premature mortality, an 11% lower risk of cardiovascular events, a 12% lower risk of coronary heart disease, a 27% lower risk of stroke, a 17% lower risk of albuminuria, and a 13% lower risk of retinopathy. Lower risks were observed among those with baseline systolic blood pressure levels ≥140 mm Hg. The findings are published in JAMA.